A detailed history of Mc Guire Investment Group, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Mc Guire Investment Group, LLC holds 51,486 shares of JNJ stock, worth $7.98 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares
51,486
Previous 51,513 0.05%
Holding current value
$7.98 Million
Previous $7.53 Million 10.81%
% of portfolio
1.19%
Previous 1.09%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$145.48 - $167.38 $3,927 - $4,519
-27 Reduced 0.05%
51,486 $8.34 Million
Q2 2024

Jul 23, 2024

SELL
$144.38 - $157.78 $508,795 - $556,016
-3,524 Reduced 6.4%
51,513 $7.53 Million
Q1 2024

Apr 26, 2024

BUY
$155.22 - $162.74 $71,401 - $74,860
460 Added 0.84%
55,037 $8.71 Million
Q4 2023

Jan 12, 2024

SELL
$145.6 - $158.88 $13,832 - $15,093
-95 Reduced 0.17%
54,577 $8.55 Million
Q3 2023

Oct 12, 2023

BUY
$155.75 - $174.48 $40,806 - $45,713
262 Added 0.48%
54,672 $8.52 Million
Q2 2023

Jul 18, 2023

SELL
$154.35 - $166.11 $287,554 - $309,462
-1,863 Reduced 3.31%
54,410 $9.01 Million
Q1 2023

Apr 20, 2023

SELL
$151.05 - $180.26 $345,451 - $412,254
-2,287 Reduced 3.91%
56,273 $8.72 Million
Q4 2022

Jan 10, 2023

BUY
$160.2 - $179.79 $38,448 - $43,149
240 Added 0.41%
58,560 $0
Q3 2022

Oct 13, 2022

SELL
$161.33 - $179.52 $79,213 - $88,144
-491 Reduced 0.83%
58,320 $9.53 Million
Q2 2022

Jul 15, 2022

SELL
$168.19 - $186.01 $156,584 - $173,175
-931 Reduced 1.56%
58,811 $10.4 Million
Q1 2022

Apr 14, 2022

SELL
$158.14 - $179.59 $1.66 Million - $1.88 Million
-10,493 Reduced 14.94%
59,742 $10.6 Million
Q4 2021

Jan 13, 2022

SELL
$155.93 - $173.01 $190,234 - $211,072
-1,220 Reduced 1.71%
70,235 $12 Million
Q3 2021

Oct 19, 2021

BUY
$161.5 - $179.47 $119,671 - $132,987
741 Added 1.05%
71,455 $11.5 Million
Q2 2021

Jul 16, 2021

SELL
$159.48 - $171.07 $129,338 - $138,737
-811 Reduced 1.13%
70,714 $11.6 Million
Q1 2021

Apr 20, 2021

BUY
$153.07 - $170.48 $677,334 - $754,374
4,425 Added 6.59%
71,525 $11.8 Million
Q4 2020

Jan 13, 2021

BUY
$137.11 - $157.38 $2.78 Million - $3.19 Million
20,250 Added 43.22%
67,100 $10.6 Million
Q3 2020

Oct 19, 2020

BUY
$140.38 - $153.83 $2.82 Million - $3.09 Million
20,065 Added 74.91%
46,850 $6.98 Million
Q2 2020

Jul 14, 2020

BUY
$128.81 - $155.51 $22,026 - $26,592
171 Added 0.64%
26,785 $3.77 Million
Q1 2020

Apr 02, 2020

SELL
$111.14 - $153.99 $16,448 - $22,790
-148 Reduced 0.55%
26,614 $3.49 Million
Q4 2019

Jan 07, 2020

SELL
$127.5 - $146.44 $1,912 - $2,196
-15 Reduced 0.06%
26,762 $3.9 Million
Q3 2019

Oct 25, 2019

BUY
$126.95 - $142.14 $3,681 - $4,122
29 Added 0.11%
26,777 $3.46 Million
Q2 2019

Jul 25, 2019

SELL
$131.15 - $144.24 $11,803 - $12,981
-90 Reduced 0.34%
26,748 $3.73 Million
Q1 2019

Apr 23, 2019

BUY
$125.72 - $139.79 $50,790 - $56,475
404 Added 1.53%
26,838 $3.75 Million
Q4 2018

Jan 28, 2019

BUY
$122.84 - $147.84 $46,310 - $55,735
377 Added 1.45%
26,434 $3.41 Million
Q3 2018

Nov 07, 2018

BUY
$121.58 - $142.88 $3.17 Million - $3.72 Million
26,057 New
26,057 $3.6 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Mc Guire Investment Group, LLC Portfolio

Follow Mc Guire Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Guire Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Guire Investment Group, LLC with notifications on news.